Cannara Biotech (TSE:LOVE) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Cannara Biotech Inc. has reported record-breaking sales growth and operating cash flow for fiscal 2024, achieving a 43% increase in annual revenue and a 3.2% national market share. The company’s strong financial performance, marked by a 14th consecutive quarter of positive Adjusted EBITDA and significant improvements in free cash flow, underscores its robust position in Canada’s cannabis market. Looking ahead, Cannara plans to expand its production capacity with new grow zones in 2025, aiming to further strengthen its market standing.
For further insights into TSE:LOVE stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Shareholder Alert for Chipotle Mexican Grill, Inc. (NYSE:CMG)
- 3 Penny Stocks to Watch Now, 11/26/24
- Rivian Gets Conditional DOE Loan of $6.6B for Georgia Plant
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
